Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Blood|November 15, 1992
Impaired erythropoietin response to anemia after bone marrow transplantationC B Miller, R J Jones, M L Zahurak, et al.
Leukemia Research|July 6, 2004
The second international congress on myeloproliferative and myelodysplastic syndromesR T Silver, J M Bennett, M Deininger, et al.
The New England Journal of Medicine|August 28, 2014
Two clinical phenotypes in polycythemia veraJerry L Spivak, Michael Considine, Donna M Williams, et al.
The Journal of Biological Chemistry|September 8, 1995
Polo-like kinase is a cell cycle-regulated kinase activated during mitosisR Hamanaka, M R Smith, P M O'Connor, et al.
Tsitologiia|July 26, 2012
[Telomere length in the population of long-lived persons of North-West region of Russia]T Iu Smirnova, A L Runov, M S Vonskiĭ, et al.
Haematologica|February 6, 2010
Sex differences in the JAK2 V617F allele burden in chronic myeloproliferative disordersBrady L Stein, Donna M Williams, Nae-Yuh Wang, et al.
Blood|March 1, 1980
Regulation of hematopoiesis: helper and suppressor influences of the thymusS J Sharkis, J L Spivak, A Ahmed, et al.
Plos One|June 2, 2020
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia veraJerry L Spivak, Akil Merchant, Donna M Williams, et al.
Haematologica|June 14, 2005
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levelsPhilipp L Goerttler, Edith März, Peter L Johansson, et al.
American Journal of Hematology|May 26, 2017
Multicenter analysis of the use of transjugular intrahepatic portosystemic shunt for management of MPN-associated portal hypertensionChristopher R Reilly, Daria V Babushok, Karlyn Martin, et al.
Pageof 16